| Intracranial Aneurysms: Treatment and Complications | Lifetime | 12 | US 10 | 99.84 |
| Neurological Complications and Syndromes | Lifetime | 4 | US 2 | 99.68 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 23 | US 12 | 99.86 |
| Neurosurgical Procedures and Complications | Lifetime | 8 | US 5 | 99.85 |
| Acute Ischemic Stroke Management | Lifetime | 48 | US 18 | 99.77 |
| Cerebrospinal fluid and hydrocephalus | Lifetime | 23 | US 16 | 99.47 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 78 | US 37 | 99.68 |
| Stroke Rehabilitation and Recovery | Lifetime | 53 | US 23 | 99.61 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 60 | US 27 | 99.43 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 32 | US 18 | 99.60 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 114 | US 45 | 99.60 |
| Cardiac Arrest and Resuscitation | Lifetime | 133 | US 75 | 99.48 |
| Moyamoya disease diagnosis and treatment | Lifetime | 28 | US 12 | 99.10 |
| Vascular Malformations Diagnosis and Treatment | Lifetime | 82 | US 58 | 99.24 |
| Neurological and metabolic disorders | Lifetime | 53 | US 25 | 98.45 |
| Infectious Encephalopathies and Encephalitis | Lifetime | 35 | US 17 | 98.43 |
| Thermal Regulation in Medicine | Lifetime | 77 | US 38 | 98.31 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 30 | US 9 | 97.78 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 495 | US 211 | 98.78 |
| Long-Term Effects of COVID-19 | Lifetime | 409 | US 101 | 96.82 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 360 | US 146 | 98.16 |
| Spinal Hematomas and Complications | Lifetime | 54 | US 38 | 97.64 |
| Cerebral Venous Sinus Thrombosis | Lifetime | 201 | US 107 | 97.37 |
| Anesthesia and Sedative Agents | Lifetime | 466 | US 206 | 97.55 |
| Myasthenia Gravis and Thymoma | Lifetime | 230 | US 72 | 96.77 |
| Electrolyte and hormonal disorders | Lifetime | 335 | US 153 | 96.85 |
| Epilepsy research and treatment | Lifetime | 788 | US 329 | 97.02 |
| Traumatic Brain Injury Research | Lifetime | 450 | US 284 | 96.83 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 435 | US 138 | 95.92 |
| Cardiovascular Health and Disease Prevention | Lifetime | 949 | US 347 | 96.16 |
| Cardiovascular and Diving-Related Complications | Lifetime | 516 | US 244 | 94.24 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 296 | US 72 | 92.88 |
| Peripheral Neuropathies and Disorders | Lifetime | 854 | US 235 | 94.37 |
| Electroconvulsive Therapy Studies | Lifetime | 919 | US 398 | 88.40 |
| Restraint-Related Deaths | Lifetime | 899 | US 351 | 81.48 |
| Traumatic Brain Injury and Neurovascular Disturbances | 2021-2025 | 69 | US 28 | 98.71 |
| Intracranial Aneurysms: Treatment and Complications | 2021-2025 | 54 | US 33 | 98.19 |
| Acute Ischemic Stroke Management | 2021-2025 | 146 | US 41 | 98.71 |
| Neurosurgical Procedures and Complications | 2021-2025 | 49 | US 24 | 97.28 |
| Neurological Complications and Syndromes | 2021-2025 | 17 | US 3 | 95.84 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 235 | US 53 | 95.72 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 504 | US 157 | 94.85 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 737 | US 193 | 95.05 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 202 | US 77 | 92.88 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 610 | US 213 | 93.58 |
| Anesthesia and Sedative Agents | 2021-2025 | 276 | US 84 | 89.60 |
| Pharmacological Effects and Toxicity Studies | 2021-2025 | 777 | US 192 | 80.22 |
| Cerebral Venous Sinus Thrombosis | 2021-2025 | 638 | US 214 | 73.43 |
| Moyamoya disease diagnosis and treatment | 2021-2025 | 740 | US 184 | 62.06 |
| Cardiovascular and Diving-Related Complications | 2021-2025 | 781 | US 160 | 60.94 |
| Neurological and metabolic disorders | 2021-2025 | 598 | US 137 | 47.20 |